| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |